Predictors of autoimmune disease: Autoantibodies and beyond

Autoimmunity

Volumn 41, Issue 6, 2008, Pages 419-428

  Rose, Noel R ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Biomarkers; Diabetes; Graves' disease; Lupus; Multiple sclerosis; Thyroiditis

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CARDIAC MYOSIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DOUBLE STRANDED DNA ANTIBODY; GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INSULIN; INTERLEUKIN 1BETA; LA ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN; MYOSIN HEAVY CHAIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; PHOSPHOLIPID ANTIBODY; RHEUMATOID FACTOR; RO ANTIBODY; SM ANTIBODY; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNINDEXED DRUG;

ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CELIAC DISEASE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; DRUG RESPONSE; EARLY DIAGNOSIS; EARLY INTERVENTION; ENVIRONMENTAL FACTOR; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GLUTEN FREE DIET; GRAVES DISEASE; HASHIMOTO DISEASE; HEREDITY; HIGH RISK POPULATION; HUMAN; IMMUNOADSORPTION; IMMUNOLOGICAL TOLERANCE; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; MYOCARDITIS; NONHUMAN; PREDICTION; PROGNOSIS; RHEUMATOID ARTHRITIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BIOLOGICAL MARKERS; CYTOKINES; DIABETES MELLITUS, TYPE 1; GENETIC MARKERS; HUMANS; MYOCARDITIS; THYROID GLAND;

EID: 51849108657     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930802031686     Document Type: Article

References (89)

1. Krischer, J. (2004) The biostatistics of prediction. Autoimmunity, 37, pp. 261-263.
2. O'Leary, PC, Feddema, PH, Michelangeli, VP, Leedman, PJ, Chew, GT Knuiman, M. et al. (2006) Investigations of thyroid hormones and antibodies based on a community health survey: The Busselton thyroid study. Clin Endocrinol (Oxf), 64, pp. 97-104.
3. Vanderpump, MP, Tunbridge, WM, French, JM, Appleton, D., Bates, D. Clark, F. et al. (1995) The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham survey. Clin Endocrinol (Oxf), 43, pp. 55-68.
4. Rose, NR (2007) Moving from prediction to prevention. The Scientist, pp. 68-76.
5. Rose, NR (2007) Prediction and prevention of autoimmune disease: A personal perspective. Ann N Y Acad Sci, 1109, pp. 117-128.
6. Vladutiu, AO and Rose, NR (1971) Autoimmune murine thyroiditis. Relation to histocompatibility (H-2) type. Science, 174, pp. 1137-1139.
7. Bacon, LD, Kite Jr., JH and Rose, NR (1974) Relation between the major histocompatibility (B) locus and autoimmune thyroiditis in obese chickens. Science, 186, pp. 274-275.
8. Rose, NR, Kong, YM and Sundick, RS (1980) The genetic lesions of autoimmunity. Clin Exp Immunol, 39, pp. 545-550.
9. Burek, CL, Hoffman, WH and Rose, NR (1982) The presence of thyroid autoantibodies in children and adolescents with autoimmune thyroid disease and in their siblings and parents. Clin Immunol Immunopathol, 25, pp. 395-404.
10. Burek, CL, Rose, NR, Najar, GM, Hoffman, WH, Gimelfarb, A., Zmijewski, CM, Polesky, HF and Hoffman, WM (1984) Autoimmune thyroid disease. Immunogenetics, pp. 207-233. Butterworths, London
11. Rose, NR and Burek, CL (1991) The interaction of basic science and population-based research: Autoimmune thyroiditis as a case history. Am J Epidemiol, 134, pp. 1073-1078.
12. Gleason, SL, Gearhart, P., Rose, NR and Kuppers, RC (1990) Autoantibodies to thyroglobulin are encoded by diverse V-gene segments and recognize restricted epitopes. J Immunol, 145, pp. 1768-1775.
13. Beisel, KW, Kong, YM, Babu, KSJ, David, CS and Rose, NR (1992) Regulation of experimental autoimmune thyroiditis: Influence of non-H-2 genes. J Immunogenet, 9, pp. 257-265.
14. Zeitlin, AA, Simmonds, MJ and Gough, SC (2007) Genetic developments in autoimmune thyroid disease: An evolutionary process. Clin Endocrinol (Oxf)
15. Schott, M., Eckstein, A., Willenberg, HS, Nguyen, TB, Morgenthaler, NG and Scherbaum, WA (2007) Improved prediction of relapse of Graves' thyrotoxicosis by combined determination of TSH receptor and thyroperoxidase antibodies. Horm Metab Res, 39, pp. 56-61.
16. Premawardhana, LD, Parkes, AB, John, R., Harris, B. and Lazarus, JH (2004) Thyroid peroxidase antibodies in early pregnancy: Utility for prediction of postpartum thyroid dysfunction and implications for screening. Thyroid, 14, pp. 610-615.
17. Mamede da Costa, S, Sieiro Netto, L, Coeli, CM, Buescu, A. and Vaisman, M. (2007) Value of combined clinical information and thyroid peroxidase antibodies in pregnancy for the prediction of postpartum thyroid dysfunction. Am J Reprod Immunol, 58, pp. 344-349.
18. Zois, C., Stavrou, I., Svarna, E., Seferiadis, K. and Tsatsoulis, A. (2006) Natural course of autoimmune thyroiditis after elimination of iodine deficiency in northwestern Greece. Thyroid, 16, pp. 289-293.
19. Barker, JM, Barriga, KJ, Yu, L., Miao, D., Erlich, HA Norris, JM et al. (2004) Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes autoimmunity study in the young (DAISY). J Clin Endocrinol Metab, 89, pp. 3896-3902.
20. Verge, CF, Gianani, R., Kawasaki, E., Yu, L., Pietropaolo, M. Chase, HP et al. (1996) Number of autoantibodies (against insulin, GAD or ICA512/ IA2) rather than particular autoantibody specificities determines risk of type I diabetes. J Autoimmun, 9, pp. 379-383.
21. Verge, CF, Gianani, R., Kawasaki, E., Yu, L., Pietropaolo, M. Jackson, RA et al. (1996) Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes, 45, pp. 926-933.
22. Mrena, S., Virtanen, SM, Laippala, P., Kulmala, P., Hannila, ML Akerblom, HK et al. (2006) Models for predicting type 1 diabetes in siblings of affected children. Diabetes Care, 29, pp. 662-667.
23. Siljander, HT, Veijola, R., Reunanen, A., Virtanen, SM, Akerblom, HK and Knip, M. (2007) Prediction of type 1 diabetes among siblings of affected children and in the general population. Diabetologia, 50, pp. 2272-2275.
24. Hampe, CS, Hall, TR, Agren, A. and Rolandsson, O. (2007) Longitudinal changes in epitope recognition of autoantibodies against glutamate decarboxylase 65 (GAD65Ab) in prediabetic adults developing diabetes. Clin Exp Immunol, 148, pp. 72-78.
25. Sosenko, JM, Krischer, JP, Palmer, JP, Mahon, J., Cowie, C. Greenbaum, CJ et al. (2008) A risk score for type 1 diabetes derived from autoantibody positive participants in the diabetes prevention trial- type 1. Diabetes Care, 31, pp. 528-533.
26. Falorni, A. and Calcinaro, F. (2002) Autoantibody profile and epitope mapping in latent autoimmune diabetes in adults. Ann N Y Acad Sci, 958, pp. 99-106.
27. van Deutekom, AW, Heine, RJ and Simsek, S. (2008) The islet autoantibody titres: Their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitus. Diabet Med, 25, pp. 117-125.
28. Haller, MJ, Gottlieb, PA and Schatz, DA (2007) Type 1 diabetes intervention trials: Where are we and where are we going?. Curr Opin Endocrinol Diabetes Obes, 14, pp. 283-287.
29. Park, H., Yu, L., Kim, T., Cho, B., Kang, J. and Park, Y. (2006) Antigenic determinants to GAD autoantibodies in patients with type 1 diabetes with and without autoimmune thyroid disease. Ann N Y Acad Sci, 1079, pp. 213-219.
30. Burek, CL, Rose, NR, Guire, KE and Hoffman, WH (1990) Thyroid autoantibodies in black and in white children and adolescents with type 1 diabetes mellitus and their first degree relatives. Autoimmunity, 7, pp. 157-167.
31. Chang, CC, Huang, CN and Chuang, LM (1998) Autoantibodies to thyroid peroxidase in patients with type 1 diabetes in Taiwan. Eur J Endocrinol, 139, pp. 44-48.
32. Maugendre, D., Sonnet, E., Derrien, C., Le Golff, MC, Grais, MC Allannic, H. et al. (1999) Combined analysis of long-term anti-beta-cell humoral reactivity in type 1 diabetes with and without thyroid disease. Diabetes Metab, 25, pp. 28-33.
33. Mantovani, RM, Mantovani, LM and Dias, VM (2007) Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus: Prevalence and risk factors. J Pediatr Endocrinol Metab, 20, pp. 669-675.
34. De Block, CE, De Leeuw, IH, Decochez, K., Winnock, F., Van Autreve, J. Van Campenhout, CM et al. (2001) The presence of thyrogastric antibodies in first degree relatives of type 1 diabetic patients is associated with age and proband antibody status. J Clin Endocrinol Metab, 86, pp. 4358-4363.
35. Arbuckle, MR, McClain, MT, Rubertone, MV, Scofield, RH, Dennis, GJ James, JA et al. (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med, 349, pp. 1526-1533.
36. McClain, MT, Arbuckle, MR, Heinlen, LD, Dennis, GJ, Roebuck, J. Rubertone, MV et al. (2004) The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. Arthritis Rheum, 50, pp. 1226-1232.
37. McClain, MT, Heinlen, LD, Dennis, GJ, Roebuck, J., Harley, JB and James, JA (2005) Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med, 11, pp. 85-89.
38. James, JA, Harley, JB and Scofield, RH (2006) Epstein-Barr virus and systemic lupus erythematosus. Curr Opin Rheumatol, 18, pp. 462-467.
39. Wandstrat, AE, Carr-Johnson, F., Branch, V., Gray, H., Fairhurst, AM Reimold, A. et al. (2006) Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus. J Autoimmun, 27, pp. 153-160.
40. Mahler, M., Mierau, R. and Bluthner, M. (2000) Fine-specificity of the anti-CENP-A B-cell autoimmune response. J Mol Med, 78, pp. 460-467.
41. Akbarali, Y., Matousek-Ronck, J., Hunt, L., Staudt, L., Reichlin, M. Guthridge, JM et al. (2006) Fine specificity mapping of autoantigens targeted by anti-centromere autoantibodies. J Autoimmun, 27, pp. 272-280.
42. Korbet, SM, Lewis, EJ, Schwartz, MM, Reichlin, M., Evans, J. and Rohde, RD (2000) Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis, 35, pp. 904-914.
43. Scofield, RH (2004) Autoantibodies as predictors of disease. Lancet, 363, pp. 1544-1546.
44. Bizzaro, N. (2007) Autoantibodies as predictors of disease: The clinical and experimental evidence. Autoimmun Rev, 6, pp. 325-333.
45. Notkins, AL (2007) New predictors of disease. Molecules called predictive autoantibodies appear in the blood years before people show symptoms of various disorders. Tests that detected these molecules could warn of the need to take preventive action. Sci Am, 296, pp. 72-79.
46. Sihvonen, S., Korpela, M., Mustila, A. and Mustonen, J. (2005) The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis. J Rheumatol, 32, pp. 2089-2094.
47. Kudo-Tanaka, E., Ohshima, S., Ishii, M., Mima, T., Matsushita, M. Azuma, N. et al. (2007) Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis. Clin Rheumatol, 26, pp. 1627-1633.
48. Bukhari, M., Thomson, W., Naseem, H., Bunn, D., Silman, A. Symmons, D. et al. (2007) The performance of anti-cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: Results from the Norfolk arthritis register. Arthritis Rheum, 56, pp. 2929-2935.
49. Mathsson, L., Mullazehi, M., Wick, MC, Sjoberg, O., van Vollenhoven, R. Klareskog, L. et al. (2008) Antibodies against citrullinated vimentin in rheumatoid arthritis: Higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides. Arthritis Rheum, 58, pp. 36-45.
50. Bobbio-Pallavicini, F., Caporali, R., Alpini, C., Moratti, R. and Montecucco, C. (2007) Predictive value of antibodies to citrullinated peptides and rheumatoid factors in anti-TNF-alpha treated patients. Ann N Y Acad Sci, 1109, pp. 287-295.
51. Casquero, P., Villoslada, P., Montalban, X. and Torrent, M. (2001) Frequency of multiple sclerosis in Menorca, Balearic islands, Spain. Neuroepidemiology, 20, pp. 129-133.
52. Berger, T., Rubner, P., Schautzer, F., Egg, R., Ulmer, H. Mayringer, I. et al. (2003) Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med, 349, pp. 139-145.
53. Kuhle, J., Pohl, C., Mehling, M., Edan, G., Freedman, MS Hartung, HP et al. (2007) Lack of association between antimyelin antibodies and progression to multiple sclerosis. N Engl J Med, 356, pp. 371-378.
54. Pelayo, R., Tintore, M., Montalban, X., Rovira, A., Espejo, C. Reindl, M. et al. (2007) Antimyelin antibodies with no progression to multiple sclerosis. N Engl J Med, 356, pp. 426-428.
55. Pittock, SJ, Reindl, M., Achenbach, S., Berger, T., Bruck, W. Konig, F. et al. (2007) Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: Frequency, stability and clinicopathologic correlations. Mult Scler, 13, pp. 7-16.
56. Lalive, PH, Menge, T., Delarasse, C., Della Gaspera, B., Pham-Dinh, D. Villoslada, P. et al. (2006) Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis. Proc Natl Acad Sci USA, 103, pp. 2280-2285.
57. Beyer, NH, Milthers, J., Bonde Lauridsen, AM, Houen, G. and Lautrup Frederiksen, J (2007) Autoantibodies to the proteasome in monosymptomatic optic neuritis may predict progression to multiple sclerosis. Scand J Clin Lab Invest, 67, pp. 696-706.
58. Liu, E., Li, M., Emery, L., Taki, I., Barriga, K. Tiberti, C. et al. (2007) Natural history of antibodies to deamidated gliadin peptides and transglutaminase in early childhood celiac disease. J Pediatr Gastroenterol Nutr, 45, pp. 293-300.
59. Westerlund, A., Ankelo, M., Simell, S., Ilonen, J., Knip, M. Simell, O. et al. (2007) Affinity maturation of immunoglobulin A anti-tissue transglutaminase autoantibodies during development of coeliac disease. Clin Exp Immunol, 148, pp. 230-240.
60. Bizzaro, N., Tozzoli, R. and Shoenfeld, Y. (2007) Are we at a stage to predict autoimmune rheumatic diseases?. Arthritis Rheum, 56, pp. 1736-1744.
61. Caforio, AL, Mahon, NG and McKenna, WJ (2006) Clinical implications of anti-cardiac immunity in dilated cardiomyopathy. Ernst Schering Res Found Workshop, pp. 169-193.
62. Magnusson, Y., Wallukat, G., Waagstein, F., Hjalmarson, A. and Hoebeke, J. (1994) Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. Circulation, 89, pp. 2760-2767.
63. Stork, S., Boivin, V., Horf, R., Hein, L., Lohse, MJ Angermann, CE et al. (2006) Stimulating autoantibodies directed against the cardiac beta 1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy. Am Heart J, 152, pp. 697-704.
64. Jahns, R., Boivin, V., Hein, L., Triebel, S., Angermann, CE Ertl, G. et al. (2004) Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest, 113, pp. 1419-1429.
65. Jahns, R., Boivin, V. and Lohse, MJ (2006) Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats. Int J Cardiol, 112, pp. 7-14.
66. Rose, NR, Wolfgram, LJ, Herskowitz, A. and Beisel, KW (1986) Postinfectious autoimmunity: Two distinct phases of Coxsackievirus B3-induced myocarditis. Ann N Y Acad Sci, 475, pp. 146-156.
67. Wolfgram, LJ, Beisel, KW, Herskowitz, A. and Rose, NR (1986) Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice. J Immunol, 136, pp. 1846-1852.
68. Herskowitz, A., Beisel, KW, Wolfgram, LJ and Rose, NR (1985) Coxsackievirus B3 murine myocarditis: Wide pathologic spectrum in genetically defined inbred strains. Human Pathol, 16, pp. 671-673.
69. Rose, NR, Beisel, KW, Herskowitz, A., Neu, N., Wolfgram, LJ, Alvarez, FL, Traystman, MD and Craig, SW (1987) Cardiac myosin and autoimmune myocarditis. Autoimmunity and autoimmune disease. Ciba foundation symposium 129, pp. 3-24. John Wiley & Sons, Ltd, Chichester, UK
70. Wolfgram, LJ, Beisel, KW and Rose, NR (1985) Heart-specific autoantibodies following murine Coxsackievirus B3 myocarditis. J Exp Med, 161, pp. 1112-1121.
71. Neu, N., Beisel, KW, Traystman, MD, Rose, NR and Craig, SW (1987) Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to Coxsackievirus B3-induced myocarditis. J Immunol, 138, pp. 2488-2492.
72. Neu, N., Rose, NR, Beisel, KW, Herskowitz, A., Gurri-Glass, G. and Craig, SW (1987) Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol, 139, pp. 3630-3636.
73. Rose, NR, Neumann, DA, Herskowitz, A., Traystman, MD and Beisel, KW (1988) Genetics of susceptibility to viral myocarditis in mice. Pathol Immunopathol Res, 7, pp. 266-278.
74. Guler, ML, Ligons, D. and Rose, NR (2005) Genetics of autoimmune myocarditis. Immunogenetics of autoimmune disease, pp. 144-151. Landis Bioscience/Eurekah.com and Springer Science, Berlin
75. Guler, ML, Ligons, DL, Wang, Y., Bianco, M., Broman, KW and Rose, NR (2005) Two autoimmune diabetes loci influencing T cell apoptosis control susceptibility to experimental autoimmune myocarditis. J Immunol, 174, pp. 2167-2173.
76. Eaton, WW, Rose, NR, Kalaydjian, A., Pedersen, MG and Mortensen, PB (2007) Epidemiology of autoimmune diseases in Denmark. J Autoimmun, 29, pp. 1-9.
77. Fairweather, DL and Rose, NR (2005) Inflammatory heart disease: A role for cytokines. Lupus, 14, pp. 1-6.
78. Fairweather, D. and Rose, NR (2007) Coxsackievirus-induced myocaraditis in mice: A model of autoimmune disease for studying immunotoxicity. Methods, 41, pp. 118-122.
79. Lane, JR, Neumann, DA, Lafond-Walker, A., Herskowitz, A. and Rose, NR (1993) Role of IL-1 and tumor necrosis factor in Coxsackie virus-induced autoimmune myocarditis. J Immunol, 151, pp. 1682-1690.
80. Neumann, DA, Lane, JR, Allen, GS, Herskowitz, A. and Rose, NR (1993) Viral myocarditis leading to cardiomyopathy: Do cytokines contribute to pathogenesis?. Clin Immunol Immunopathol, 68, pp. 181-190.
81. Kaya, Z., Afanasyeva, M., Wang, Y., Dohmen, KM, Schlichting, J., Tretter, T., Fairweather, D., Holers, VM and Rose, NR (2001) Contribution of the innate immune system to autoimmune myocarditis: A role for complement. Nat Immunol, 2, pp. 739-745.
82. Kaya, Z. and Rose, NR (2005) Innate immunity in experimental autoimmune myocarditis. Molecular autoimmunity, pp. 1-12. Springer Science+Business Media, Inc., New York
83. Afanasyeva, M., Wang, Y., Kaya, Z., Stafford, EA, Dohmen, KM, Sadighi Akha, AA and Rose, NR (2001) Interleukin-12 recepter/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-independent pathway. Circulation, 104, pp. 3145-3151.
84. Afanasyeva, M. and Rose, NR (2002) Immune mediators in inflammatory heart disease: Insights from a mouse model. Eur Heart J, 4, pp. 131-146.
85. Rose, NR and Afanasyeva, M. (2003) The inflammatory process in experimental myocarditis. Inflammation and heart disease, pp. 325-333. Birkhauser Verlag, Basel
86. Afanasyeva, M., Georgakopoulos, D. and Rose, NR (2004) Autoimmune myocarditis: Cellular mediators of cardiac dysfunction. Autoimmun Rev, 3, pp. 476-486.
87. Sharp, V. and Utz, PJ (2007) Technology insight: Can autoantibody profiling improve clinical practice?. Nat Clin Pract Rheumatol, 3, pp. 96-103.
88. Ahn, AC, Tewari, M., Poon, CS and Phillips, RS (2006) The clinical applications of a systems approach. PLoS Med, 3, p. e209.
89. Shepshelovich, D. and Shoenfeld, Y. (2006) Prediction and prevention of autoimmune diseases: Additional aspects of the mosaic of autoimmunity. Lupus, 15, pp. 183-190.